Details

Autor(en) / Beteiligte

• Ozeki, Toshikazu
• Mizuno, Masashi
• Iguchi, Daiki
• Kojima, Hiroshi
• Kim, Hangsoo
• Suzuki, Yasuhiro
• Kinashi, Hiroshi
• Ishimoto, Takuji
• Maruyama, Shoichi
• Ito, Yasuhiko

Titel

C1 inhibitor mitigates peritoneal injury in zymosan-induced peritonitis

Ist Teil von

• American journal of physiology. Renal physiology, 2021-06, Vol.320 (6), p.F1123-F1132

Ort / Verlag

United States: American Physiological Society

Erscheinungsjahr

2021

Quelle

EZB Electronic Journals Library

Beschreibungen/Notizen

• Peritonitis, due to a fungal or bacterial infection, leads to injury of the peritoneal lining and thereby forms a hazard for the long-term success of PD, and remains a lethal complication in PD patients. This study investigated whether C1 inhibitor (C1-INH) could protect against the progression of peritoneal injuries with five daily administrations of zymosan after mechanical scraping of rat peritoneum to mimic fungal peritonitis. Severe peritoneal injuries were seen in this model, accompanied by fibrinogen/fibrin exudation and peritoneal deposition of complement activation products such as activated C3 and C5b-9. However, intraperitoneal injection of C1-INH decreased peritoneal depositions of activated C3 and C5b-9, ameliorated peritoneal thickening and reduced influx of inflammatory cells and prevented production of peritoneal fibrous layers with both one and two doses of C1-INH each day. Our results suggest that C1-INH might be useful to protect against peritoneal injuries after causes of peritonitis such as fungal infections. This clinically available agent may thus help extend the duration of PD.